SCHEMBL26423650

SCHEMBL26423650

c1cc2cc3sc4cncnc4c3cc2cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HASPIN Q8TF76 11/20 0.40
PIM1 P11309 5/20 0.37
CDK9 P50750 4/20 0.37
CCNT1 O60563 3/20 0.37
MKNK2 Q9HBH9 1/20 0.37
CYP2A6 P11509 4/20 0.36
CLK1 P49759 2/20 0.36
DYRK1A Q13627 2/20 0.36
CSNK1D P48730 1/20 0.36
CSNK1E P49674 1/20 0.36
LIMK1 P53667 2/20 0.35
CHEK1 O14757 1/20 0.35
AURKA O14965 1/20 0.35
DAPK3 O43293 1/20 0.35
PRKD3 O94806 1/20 0.35
MAP4K4 O95819 1/20 0.35
PAK4 O96013 1/20 0.35
ABL1 P00519 1/20 0.35
RET P07949 1/20 0.35
FGFR1 P11362 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26423651 1.00 HASPIN (0.40) HASPINPIM1CDK9CCNT1MKNK2
SCHEMBL22483175 0.86 EGFR (0.39) CYP2A6LIMK1CDK5
SCHEMBL26423606 0.82 CLK1 (0.39) HASPINPIM1CDK9CCNT1CYP2A6
SCHEMBL26423617 0.82 CLK1 (0.39) HASPINPIM1CDK9CCNT1CYP2A6
SCHEMBL26423593 0.79 HASPIN (0.41) HASPINPIM1CDK9CCNT1CYP2A6
SCHEMBL26423594 0.79 HASPIN (0.41) HASPINPIM1CDK9CCNT1CYP2A6
SCHEMBL26423635 0.79 HASPIN (0.40) HASPINPIM1CDK9CCNT1MKNK2
SCHEMBL26423637 0.79 HASPIN (0.40) HASPINPIM1CDK9CCNT1MKNK2
SCHEMBL22483133 0.79 KDM4E (0.36) PIM1CDK9CYP2A6CLK1DYRK1A
SCHEMBL22483136 0.77 CYP2A6 (0.33) PIM1CDK9CYP2A6CLK1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2023-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127291-A1 HETEROCYCLIC ARYLAMINE COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE AND DISPLAY PANEL OCIAD2, OCIAD1, AZI2 HASPIN 2934/4885PIM1 3895/4885CDK9 823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.